Purpose To evaluate the outcomes of patients with septic shock treated with a combination
of norepinephrine with phenylephrine compared to norepinephrine with vasopressin …

Background: There is little data guiding clinicians on how to discontinue vasopressors
among septic shock patients on concomitant norepinephrine (NE) and vasopressin (VP) …

Background: Delays in achievement of target mean arterial pressure (MAP) have been
associated with increased mortality in patients with septic shock. Vasopressin may be added …

When fluid challenge fails to restore an adequate arterial pressure and organ perfusion,
therapy with vasopressor agents should be initiated [1]. Potential agents that can be …

To determine the effects on hemodynamics, laboratory parameters, and renal function of
terlipressin used in septic-shock patients with hypotension not responsive to high-dose …

Arginine vasopressin (AVP) and its synthetic, long-acting analog terlipressin (TP) are potent
alternative vasoconstrictors in the treatment of septic patients with catecholamine-refractive …

Septic shock, a variety of distributive shock secondary to sepsis, is the most common form of
circulatory failure encountered in the ICU (1). This infectious syndrome is a result of severe …

Background Vasopressors are administered to critically ill patients with vasodilatory shock
not responsive to volume resuscitation, and less often in cardiogenic shock, and …

Purpose We performed an individual patient data meta-analysis to investigate the possible
benefits and harms of vasopressin therapy in adults with septic shock both overall and in pre …

Background Despite the dissemination of international guidelines, mortality from septic
shock remains high. Norepinephrine is recommended as first-line vasopressor therapy with …